
Ursodeoxycholic Acid
Ursodeoxycholic acid is a bile acid found in the bile of bears (Ursidae) as a conjugate with taurine. Used therapeutically, it prevents the synthesis and absorption of cholesterol and can lead to the dissolution of gallstones. It has a role as a mouse metabolite and a human metabolite. It is a C24-steroid, a dihydroxy-5beta-cholanic acid and a bile acid. It is a conjugate acid of an ursodeoxycholate. — ChEBI
- IUPAC 名称
- (4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
- 分子式
- C24H40O4
- 分子量
- 392.6 g/mol
- 精确质量
- 392.29265975 Da
- XLogP3
- 4.9
- 拓扑极性表面积
- 77.8 Ų
- 氢键供体
- 3
- 氢键受体
- 4
- 共价单元
- 1
- 已定义的立体中心
- 10
又称
另有 16 个已报告名称
外部数据库标识符
- ChEBI:CHEBI:9907
- ChEMBL:CHEMBL1551
- EPA DTXSID:DTXSID6023731
- PubMed:38244730
- PubMed:38104874
- PubMed:37968239
- PubMed:36473578
- PubMed:36470304
- PubMed:34461081
- PubMed:34155936
- PubMed:34079822
- PubMed:33568795
- PubMed:32679164
- PubMed:32198087
- PubMed:31299240
来自其他科学数据库的证据
NIH PubChem PUG-View
Attributed physical-property, hazard, environmental and use annotations.
- LogP: 3 来源: DrugBank
- LogP: 3.00 来源: Human Metabolome Database (HMDB)
- Melting Point: 200-205 来源: DrugBank
- Melting Point: 203 °C 来源: Human Metabolome Database (HMDB)
- Physical Description: Solid 来源: Human Metabolome Database (HMDB)
- Solubility: 0.02 mg/mL 来源: Human Metabolome Database (HMDB)
- Note: This chemical does not meet GHS hazard criteria for 4.5% (2 of 44) of reports. 来源: European Chemicals Agency (ECHA)
- Signal: Warning 来源: European Chemicals Agency (ECHA)
- GHS Hazard Statements: H315 (95.5%): Causes skin irritation [Warning Skin corrosion/irritation]; H319 (95.5%): Causes serious eye irritation [Warning Serious eye damage/eye irritation] 来源: European Chemicals Agency (ECHA)
- Precautionary Statement Codes: P264, P264+P265, P280, P302+P352, P305+P351+P338, P321, P332+P317, P337+P317, and P362+P364 (click each P-code to see the statement) 来源: European Chemicals Agency (ECHA)
- ECHA C&L Notifications Summary: Aggregated GHS information provided per 44 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 2 of 44 reports by companies.; There are 3 notifications provided by 42 of 44 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. 来源: European Chemicals Agency (ECHA)
- Toxicity Summary: UDCA has been shown to have potentially toxic molecular properties. UDCA breaks down into toxic lithocholic acid. After being absorbed in the small intestine, UDCA undergoes hepatic conjugation. Beyond conjugation, UDCA does not experience further breakdown by the liver or intestinal mucosa. It becomes oxidized or reduced, yielding either 7-keto-lithocholic acid or lithocholic acid. Litcholic acid can be toxic to liver cells and even cause liver failure in those with compromised sulfation. It also leads to segmental bile duct injury, hepatocyte failure, and death. 来源: StatPearls
- Uses: Use (kg; approx.) in Germany (2009): >10000; Use (kg) in USA (2002): 6870; Consumption (g per capita; approx.) in Germany (2009): 0.122; Consumption (g per capita) in the USA (2002): 0.0244; Excretion rate: 1; Calculated removal (%): 73.4 来源: NORMAN Suspect List Exchange
映射方: Existing checksum-valid CAS to unique PubChem CID match. 检索时间: 2026-08-31. 打开来源记录
科学分类和危害注释仅提供背景信息,不能取代上方所示针对具体市场的监管决定。
其他来源的覆盖范围和匹配状态
| 来源 | 结果 | 已检查 |
|---|---|---|
| NIH PubChem PUG-View | 精确匹配 | 2026-08-31 |
已记录的无匹配结果是该来源已被检查的有效证据;这并不表示该物质在别处不存在。
于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。